RxDoctor Payments Data

David Waters

Foot & Ankle Surgery · Hastings, NENPI 1386932564

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $159,508 of the $213,882 with a category attached, or 74.6%. Paragon 28, Inc. accounts for 95.6% of it on its own, with 23 other manufacturers making up the rest. Reporting peaked in 2021 at $66,503 and has fallen 98.4% since, to $1,035 in 2025. Among foot & ankle surgery clinicians in NE with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$213,882in general payments, 2019–2025

Across 147 payments — averaging $1454.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Paragon 28, Inc.$204K
  • Osteomed LLC$8K
  • International Life Sciences$425
  • Zimmer Biomet$242
  • Acumed LLC$222
  • Stryker$202
  • plus $827 from 18 others

What the payments were for

  • Consulting fees$159,50875%
  • Speaking & faculty fees$2,5001%
  • Grants$25,00012%
  • Travel & lodging$20,36410%
  • Food & beverage$6,5103%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$213,882 in reported general payments places this provider in the 95th percentile of 43 foot & ankle surgery providers in Nebraska.

See all foot & ankle surgery providers in Nebraska

Medicare billing

Part B allowed, 2024
$141,577
Medicare patients
359
Services billed
1,773

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cephalexin13$119

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Hastings

See the full list for Nebraska

Where these figures come from

Is this you, or does something look wrong? →